Reinhard E Friedrich1, Jozef Zustin2,3, Andreas M Luebke4, Thorsten Rosenbaum5, Martin Gosau6, Christian Hagel7, Felix K Kohlrusch6, Ilse Wieland8, Martin Zenker8. 1. Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany; rfriedrich@uke.de. 2. Institute of Osteology and Biomechanics, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany. 3. Institute of Pathology, Gemeinschaftspraxis Pathologie-Regensburg, Regensburg, Germany. 4. Institute of Pathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany. 5. Department of Pediatrics, Sana-Kliniken Duisburg, Duisburg, Germany. 6. Oral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany. 7. Institute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany. 8. Institute of Human Genetics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Abstract
BACKGROUND/AIM: Neurofibromatosis type 1 (NF) is an autosomal dominant hereditary disease. The cardinal clinical findings include characteristic skeletal alterations. Difficulties in diagnosis and therapy can arise if an individual has further illnesses. CASE REPORT: This is a case report of a 16-year-old patient affected by NF1. She also suffered from Alagille syndrome and the consequences of fetal alcohol exposure. The patient's facial phenotype showed findings that could be assigned to one or more of the known diseases. The patient was referred for treating a cherubism-like recurrent central giant cell granuloma (CGCG) of the jaw. The patient developed bilateral, multilocular non-ossifying fibromas (NOF) of the long bones of the lower extremity. Treatment of the skeletal lesions consisted of local curettage. While NOF regressed after surgery, the CGCG of the jaw remained largely unchanged. Extensive genetic tests confirmed a previously unknown germline mutation in the JAG1 gene, the germline mutation of the NF1 gene, and the somatic mutation in the NF1 gene in the diffuse plexiform neurofibroma, but not in the CGCG. CONCLUSION: Assigning facial findings to a defined syndrome is ambiguous in many cases and especially difficult in patients who have multiple diseases that can affect the facial phenotype. Surgical therapy should be adapted to the individual findings. Copyright
BACKGROUND/AIM: Neurofibromatosis type 1 (NF) is an autosomal dominant hereditary disease. The cardinal clinical findings include characteristic skeletal alterations. Difficulties in diagnosis and therapy can arise if an individual has further illnesses. CASE REPORT: This is a case report of a 16-year-old patient affected by NF1. She also suffered from Alagille syndrome and the consequences of fetal alcohol exposure. The patient's facial phenotype showed findings that could be assigned to one or more of the known diseases. The patient was referred for treating a cherubism-like recurrent central giant cell granuloma (CGCG) of the jaw. The patient developed bilateral, multilocular non-ossifying fibromas (NOF) of the long bones of the lower extremity. Treatment of the skeletal lesions consisted of local curettage. While NOF regressed after surgery, the CGCG of the jaw remained largely unchanged. Extensive genetic tests confirmed a previously unknown germline mutation in the JAG1 gene, the germline mutation of the NF1 gene, and the somatic mutation in the NF1 gene in the diffuse plexiform neurofibroma, but not in the CGCG. CONCLUSION: Assigning facial findings to a defined syndrome is ambiguous in many cases and especially difficult in patients who have multiple diseases that can affect the facial phenotype. Surgical therapy should be adapted to the individual findings. Copyright
Authors: Anton Lavell; Christopher W Jones; Daniel Wong; Peter Counsel; Richard Carey-Smith Journal: Skeletal Radiol Date: 2017-06-16 Impact factor: 2.199
Authors: Carolina C Gomes; Marina G Diniz; Victor C Bastos; Vanessa F Bernardes; Ricardo S Gomez Journal: J Pathol Date: 2019-12-18 Impact factor: 7.996
Authors: David T Miller; Debra Freedenberg; Elizabeth Schorry; Nicole J Ullrich; David Viskochil; Bruce R Korf Journal: Pediatrics Date: 2019-05 Impact factor: 7.124
Authors: Reinhard E Friedrich; Jonathan Rother; Georg Christ; Marten Lehmann; Christine Gräfin Zu Eulenburg; Manfred Giese; Hanna A Scheuer Journal: Anticancer Res Date: 2013-03 Impact factor: 2.480
Authors: Dmitry José de Santana Sarmento; Sérgio Henrique Gonçalves de Carvalho; José Cadmo Wanderley Peregrino de Araújo; Marianne de Vasconcelos Carvalho; Éricka Janine Dantas da Silveira Journal: An Bras Dermatol Date: 2017 Mar-Apr Impact factor: 1.896